Terug
Dagbereik
€ 16,97
€ 17,35
52-Weeksbereik
€ 16,24
€ 45,30
Volume
881.508
50D / 200D Gem.
€ 19,12
/
€ 29,31
Vorige Slotkoers
€ 17,23
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -10,6 | 0,4 |
| P/B | 3,2 | 2,9 |
| ROE % | -29,1 | 3,9 |
| Net Margin % | -28,9 | 3,8 |
| Rev Growth 5Y % | 96,8 | 10,0 |
| D/E | 0,4 | 0,2 |
Koersdoel Analisten
Hold
€ 58,60
+242.9%
Low: € 24,00
High: € 75,00
Forward K/W
71,6
Forward WPA
€ 0,24
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,4 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 2,13
€ 1,80 – € 2,44
|
2,8 B | 1 |
| FY2029 |
€ 1,95
€ 1,64 – € 2,23
|
2,5 B | 1 |
| FY2028 |
€ 1,72
€ 1,45 – € 1,97
|
2,1 B | 1 |
Belangrijkste Punten
Revenue grew 96,76% annually over 5 years — strong growth
Debt/Equity of 0,41 — conservative balance sheet
Negative free cash flow of -168,04M
Revenue growth is decelerating — 1Y growth trails 5Y average by 32,29%
Capital efficient — spends only 6,55% of revenue on capex
Groei
Revenue Growth (5Y)
96,76%
Revenue (1Y)64,47%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-29,14%
ROIC-7,25%
Net Margin-28,85%
Op. Margin-13,27%
Veiligheid
Debt / Equity
0,41
Current Ratio1,96
Interest Coverage-6,38
Waardering
P/E Ratio
-10,62
P/B Ratio3,15
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 64,47% | Revenue Growth (3Y) | 90,21% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 96,76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,03B | Net Income (TTM) | -297,58M |
| ROE | -29,14% | ROA | -17,16% |
| Gross Margin | 60,34% | Operating Margin | -13,27% |
| Net Margin | -28,85% | Free Cash Flow (TTM) | -168,04M |
| ROIC | -7,25% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,41 | Current Ratio | 1,96 |
| Interest Coverage | -6,38 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -10,62 | P/B Ratio | 3,15 |
| P/S Ratio | 3,06 | PEG Ratio | -0,21 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 3,16B | Enterprise Value | 2,67B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,03B | 627,24M | 285,14M | 117,01M | 68,83M |
| Net Income | -297,58M | -177,03M | -518,25M | -446,35M | -403,58M |
| EPS (Diluted) | -1,60 | -0,97 | -2,94 | -2,81 | -2,74 |
| Gross Profit | 622,44M | 392,66M | 140,93M | 51,64M | 68,83M |
| Operating Income | -136,86M | -303,24M | -439,49M | -455,62M | -392,29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,73B | 1,67B | 1,85B | 1,33B | 1,12B |
| Total Liabilities | 723,60M | 629,61M | 597,24M | 586,65M | 353,52M |
| Shareholders' Equity | 1,00B | 1,04B | 1,25B | 744,31M | 765,94M |
| Total Debt | 413,70M | 350,60M | 328,67M | 284,53M | 122,97M |
| Cash & Equivalents | 901,90M | 286,75M | 1,28B | 786,03M | 688,94M |
| Current Assets | 1,25B | 1,28B | 1,50B | 1,10B | 949,85M |
| Current Liabilities | 636,40M | 277,65M | 216,42M | 297,79M | 229,20M |